Default company panoramic image

Integra Medical Inc.

Revolutionizing cavities prevention: proprietary, natural and affordable products for reducing tooth decay in children and adults

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location London, ON, Canada
  • Currency USD
  • Founded April 2008
  • Employees 7
  • Website

Company Summary

Integra Medical Inc. develops and commercializes advanced clinically proven probiotic products as therapies in large untapped indications. Our newest product platform, offering a breakthrough natural and preventative solution for one of the most significant worldwide dental diseases, dental caries (also known as tooth decay or cavities), represents a blockbuster market opportunity exceeding $500M in the U.S. alone and $1B globally.


  • Default avatar
    Natalya Ioudina, MA, MBA

    Business professional with solid entrepreneurial, strategic planning, financial management, operations, international business development skills. Over 17 years of executive level experience in a start-up environment in the international trade, medical device, pharmaceutical, and healthcare industries in Canada, United States (New York, NY) and Russia. Holds M.A. (Hons.) degree from New York University (1998) and an MBA degree from the Ivey Schoo

  • Default avatar
    Robert Maloley
    Strategic Business Development

    Mr. Maloley’s career spans 35 years as an entrepreneur across multiple industries and disciplines including retail, wholesale, distribution, manufacturing and software development. Bob has over 25 years of sales and marketing experience in North America, the Asia Pacific Rim, Germany and the UK. Mr. Maloley has served in an advisory capacity to a number of private and publicly traded companies and participated in the funding of a number of ventu

  • Default avatar
    Jeremy Burton, BSc, MSc, PhD, dBA
    Senior Scientific Consultant/Advisor

    Dr. Jeremy Burton brings to Integra an extensive knowledge of probiotics from both the microbiological/research and commercialization perspectives. He started in probiotic research as a student of Professor Gerald Tannock at the University of Otago, New Zealand and his PhD was in part undertaken at the Nestle Research Centre in Lausanne in Switzerland. He first came to the Lawson Health Research Institute and the University of Western Ontario as

  • Default avatar
    Peter Cadieux, MSc, PhD
    Senior Scientific Consultant/Advisor

    Dr. Peter Cadieux held the position of the inaugural Miriam Burnett Research Chair in Urological Sciences since 2009 and an Assistant Professor in the Departments of Surgery (Urology) and Microbiology & Immunology at the Schulich School of Medicine & Dentistry at The University of Western Ontario (Western) since 2006 until September 2012. Currently a Professor of Immunology and Microbiology at Fanshawe College in London, he also continues his app

  • Default avatar
    Inga Machula, BSc (Pharm.), RAC
    Regulatory affairs

    Regulatory affairs expert with over 16 years of global experience in Regulatory Affairs and Quality Assurance including submissions with Health Canada, European Regulatory Affairs Agency and the Russian Ministry of Health. Sound knowledge of Canadian Food and Drug Act and Regulations, cGMPs and guidelines for drugs and other health products. Experienced to handle GMP regulatory inspections. B.Sc. degree in Pharmacy; Academy of Applied Pharmaceuti


  • Default avatar
    McNeill Edmundson LLP; KPMG